Ramon Bataller Profile Banner
Ramon Bataller Profile
Ramon Bataller

@rabataller

Followers
11,716
Following
1,088
Media
845
Statuses
3,315

Chair, Liver Unit, Hospital Clinic, Barcelona.

Barcelona, Spain
Joined December 2010
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@rabataller
Ramon Bataller
1 year
Happy to share with you our review on ALCOHOL-ASSOCIATED HEPATITIS, published today in the @NEJM . We dedicate it to all our patients. We will continue to work together to beat it. @Dr_Vijay_Shah @juanpabloarab #LiverTwitter #MedTwitter
Tweet media one
70
467
2K
@rabataller
Ramon Bataller
2 years
My dad, Ramon Bataller Sr., died today. He was a hepatologist who conveyed to me the love for liver patients, especially those with alcohol problems. I want to thank a generation of hepatologists who, like my father, inspired us. #LiverMtg21 #LiverTwitter @AASLDtweets
Tweet media one
115
17
564
@rabataller
Ramon Bataller
2 years
Today I start as a Chair of the Liver Unit in the Hospital Clinic, Barcelona. It is an honor to be back in such a great hospital. I am excited to serve the patients and a wonderful group of hepatologists. @hospitalclinic @liverunitclinic @BCLC_group @LiverIcu #LiverTwitter
85
30
547
@rabataller
Ramon Bataller
2 years
The most dangerous phase in a doctor career is when you start thinking your are an expert but actually you DON’T KNOW WHAT YOU DON’T KNOW. It happened to me what I was in my 30s. #livertwitter #MedTwitter
Tweet media one
16
137
451
@rabataller
Ramon Bataller
2 years
Mentoring advice: be ambitious, but never consider other colleagues working in your field as rivals. Instead, cooperate to beat the disease your are working on. Federer & Nadal showed us the path. They are my role models. #ThankYouRoger #livertwitter
Tweet media one
7
83
419
@rabataller
Ramon Bataller
1 year
60 years ago today, Dr. Thomas Starzl and his team did the 1st liver transplant. His pioneer work paved way for modern organ transplant, saving countless lives. #donatelife #LiverTwitter #MedTwitter @UPMC
Tweet media one
1
98
404
@rabataller
Ramon Bataller
8 months
Today in my clinic I realized how difficult is to treat SYMPTOMS in cirrhosis: 🔸 Pain 🔸 Itching 🔸 Muscle cramps 🔸 Appetite and sadness This REVIEW helped me to find some practical solutions. #livertwitter #medtwitter
Tweet media one
5
109
373
@rabataller
Ramon Bataller
2 years
Today is my last day working as a doctor in the USA. It was an honor to work at @UNCGastro and @PittGILiverNutr My main reward has been serving American patients, especially those with alcohol problems. Thanks to all and see you in Barcelona ! #livertwitter @AASLDtweets
35
16
360
@rabataller
Ramon Bataller
1 year
How to manage PORTAL VEIN THROMBOSIS in people with cirrhosis and non-cirrhotics ? 🔸What pro-thrombotic work up ? 🔸When and what type of anticoagulant ? 🔸For how long ? This excellent review in @JHEP_Reports tell you all. #LiverTwitter #medtwitter
Tweet media one
1
105
268
@rabataller
Ramon Bataller
2 years
A new paper and a tribute. We show in a global study that MELD best predicts 28d mortality in Alc Hep and that Maddrey's DF should not be used. I presented this in Johns Hopkins, and Dr. Maddrey congratulated me. A true gentleman. #livertwitter #medtwitter
Tweet media one
8
67
258
@rabataller
Ramon Bataller
1 year
A must-read review on ACUTE KIDNEY INJURY in cirrhosis in @NEJM by the great @ggarciatsao . AKI commonly complicates cirrhosis. The management and emerging therapies are deeply discussed. #livertwitter #MedTwitter
Tweet media one
1
106
247
@rabataller
Ramon Bataller
11 months
This is my minimalist view of the new #NAFLDnomenclature : 🔸Mostly metabolic: MASLD 🔸Dual metabolic & alcohol: MetALD 🔸Mostly alcohol: ALD #EASLCongress @EASLedu @EASLnews @AASLDtweets @alehlatam @marurinella @GCastro_NarroMD @norahterrault
Tweet media one
8
103
245
@rabataller
Ramon Bataller
7 months
How to treat AUTOIMMUNE HEPATITIS ? Prof. Manns proposes this algorithm in: - AIH without cirrhosis - AIH with cirrhosis - Acute severe AIH #livertwitter #medtwittwer
Tweet media one
4
75
245
@rabataller
Ramon Bataller
6 months
Great results from the first clinical trial testing NALTREXONE vs placebo in alcohol-related cirrhosis, today at #TLM23 : 🔸Naltrexone is well tolerated 🔸It favors abstinence 🔸It reduces by 50% new onset decompensation @AASLDtweets #livertwitter #MedTwitter @ILBS_India
Tweet media one
8
82
235
@rabataller
Ramon Bataller
3 months
What is new in HEPATORENAL SYNDROME ? This great review provides an update on: 🔸Role of systemic inflammation 🔸Pharmacological therapy 🔸Indications of RRT and liver-kidney transplant @AmerGastroAssn #livertwitter #MedTwitter
Tweet media one
6
92
196
@rabataller
Ramon Bataller
2 years
Finally, a study assessing NALTREXONE for alcohol use disorder in liver patients ! It seems safe in compensated cirrhosis. I am increasingly using it, yet RCTs are warranted. #Livertwitter @ebtapper @norahterrault
Tweet media one
3
65
195
@rabataller
Ramon Bataller
2 years
This paper will be transformational: 25% of patients with presumed NAFLD were drinking ALCOHOL excessively. Some patients admitted it, but many others underreported it. “THE DIAGNOSIS OF NAFLD SHOULD REQUIRE NEGATIVE ALCOHOL METABOLITES”. #LiverTwitter
Tweet media one
11
66
194
@rabataller
Ramon Bataller
1 year
How to manage people with NAFLD ? 🔸How can we identify HIGH RISK patients? 🔸What patients should be referred to a hepatologist? This review summaries the NAFLD management ALGORITHMS proposed by major international societies. #livertwitter #medtwitter
Tweet media one
4
97
192
@rabataller
Ramon Bataller
1 year
Abdominal obesity increases alcohol-related liver toxicity by 4-fold. I showed this picture to a patient with obesity that asked me if it was OK to drink 2 beers per day. #livertwitter #medtwitter
Tweet media one
11
61
188
@rabataller
Ramon Bataller
4 months
Happy to share the new @AmCollegeGastro "Clinical Guideline: Alcohol-Associated Liver Disease": 🔸Increasing in young women 🔸Early detection needed 🔸Criteria for early LT for AH @AmCollegeGastro #livertwitter #MedTwitter
Tweet media one
8
68
182
@rabataller
Ramon Bataller
6 months
Great review on LIVER TRANSPLANTATION in the @NEJM by Lucey, Furuya & Foley: 🔸Indications 🔸Assessment 🔸Current trends & challenges #livertwitter #MedTwitter @AASLDtweets @EASLedu
Tweet media one
5
55
182
@rabataller
Ramon Bataller
9 months
The LiverRisk score, a study including 15,000 people, just released in @TheLancet : 🔸Based on simple liver function tests. 🔸It predicts liver fibrosis and liver-related outcomes in the general population. #livertwitter #medtwitter : @Liver_Screen
Tweet media one
3
61
176
@rabataller
Ramon Bataller
9 months
This study including 27 million people shows increased risk of developing liver disease in people undergoing CHOLECYSTECTOMY. Strict indications should be imlemented to reduce unnecessary cholecystectomy. #livertwitter #medtwitter
Tweet media one
7
64
172
@rabataller
Ramon Bataller
5 months
Why AST is increased in advanced fibrosis and is included in serum tests (FIB-4, APRI and LiverRisk score) ? 🔸AST is mostly in the mitochondria and is released in advanced disease. 🔸AST is increased by alcohol, a strong fibrogenic factor. #livertwitter #medtwitter @EASLedu
Tweet media one
1
47
167
@rabataller
Ramon Bataller
5 months
I get many patients in my clinic with HIGH FERRITIN. If I suspect alcohol, I don’t request HFE genetic tests the first visit. Instead, I assist them to stop drinking and I test FERRITIN again. In most cases, iron tests normalize after abstinence. #livertwitter #medtwittwer
11
25
169
@rabataller
Ramon Bataller
1 year
Important study by @DrLoomba in @JHepatology : 🔸1 out of 7 diabetics have advanced liver fibrosis. 🔸 If they are obese, 1 out of 5. With these numbers, SCREENING of liver fibrosis should be mandatory in people with type 2 diabetes. #livertwitter #MedTwitter @EASLedu
Tweet media one
8
68
165
@rabataller
Ramon Bataller
3 months
Good news for MASLD just published in the @NEJM ! Resmetirom, a selective agonist of THR-β, reduces fibrosis and steatohepatitis. Once approved, real world data will be important. #livertwitter #MedX
Tweet media one
3
45
165
@rabataller
Ramon Bataller
2 months
How to select patients with alcohol-associated hepatitis for EARLY liver transplantation ? I think this practical algorithm is very useful. @juanpabloarab @LuisAntonioDiaz @DrLoomba @APandT
Tweet media one
2
70
163
@rabataller
Ramon Bataller
1 year
Why NAFLD favors metabolic and cardiovascular diseases ? The role of HEPATOKINES may be the answer. This excellent review in @Cell_Metabolism explains it all. #livertwitter #MedTwitter
Tweet media one
3
55
162
@rabataller
Ramon Bataller
1 year
Why fatty liver favors hepatic METASTASES ? This brilliant study by @SekiEki proves that extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. #livertwitter #MedTwitter
Tweet media one
3
60
157
@rabataller
Ramon Bataller
4 months
Today I asked our fellows to write a list with the long-term Side Effects of Omeprazol (in red the most relevant for liver patients). We came out with this list: #livertwitter #MedTwitter
Tweet media one
6
60
159
@rabataller
Ramon Bataller
10 months
Patients with decompensated alcohol-related cirrhosis that achieve abstinence are able to recompensate and improve their survival. It’s NEVER TOO LATE to stop drinking !! #livertwitter #medrwitter
Tweet media one
1
45
157
@rabataller
Ramon Bataller
2 years
Differentiating between alcohol withdrawal & encephalopathy is very important in patients with Alc Hep. Don't rely only on ammonia levels. The TIMING from the last drink and the TYPE of symptoms can help. #livertwitter
Tweet media one
6
61
157
@rabataller
Ramon Bataller
2 years
Is safe for a patient with alcoholic liver disease to drink ALCOHOL-FREE BEER ? I don't recommend it: ▪️It still has some alcohol (0.1-0.5%) ▪️Patient keeps doing a bad habit ▪️We showed that it predicts relapse #livertwitter #MedTwitter
Tweet media one
7
47
156
@rabataller
Ramon Bataller
1 year
How to evaluate and refer patients with NAFLD across primary care and GI/Hepatology settings ? The new @AASLDtweets Clinical Guidelines on NAFLD by @marurinella @DrLoomba et al. proposes a practical algorithm. #LiverTwitter #medtwitter
Tweet media one
3
59
156
@rabataller
Ramon Bataller
2 years
This large study on the use of PROTON PUMP INHIBITORS in cirrhosis has important clinical implications: 🔸PPIs can favor infections and decompensation. 🔸They are only beneficial in patients with a previous GI bleed. #livertwitter #medtwitter
Tweet media one
0
62
150
@rabataller
Ramon Bataller
1 year
Novel convincing paper showing that BETA-BLOCKERS prevent liver decompensation. The great hepatologist-statistician @JuanAbraldes led this effort. #livertwitter @aeeh @AASLDtweets @HEP_Journal
Tweet media one
3
51
152
@rabataller
Ramon Bataller
3 years
Today, Dr. Miquel Navasa retired from the Hospital Clinic of Barcelona. In my career, I've never met a physician with a better clinical eye. Thanks, Miquel for your service to so many patients and for training many of us. Your greatness will never retire. @liverunitclinic
Tweet media one
6
19
148
@rabataller
Ramon Bataller
9 months
Read our review in @NatRevGastroHep on the intersection between alcohol and metabolic-associated liver disease. We need combined lifestyle changes and novel medications. #livertwitter #MedTwitter
Tweet media one
2
54
150
@rabataller
Ramon Bataller
1 year
In current hepatology, with the majority of hospitalized patients with alcohol-related liver disease, I think it would be very useful if liver FELLOWS have a brief rotation in ADDICTION MEDICINE. #MedTwitter #livertwitter @EASLedu @AASLDtweets
10
24
149
@rabataller
Ramon Bataller
1 year
New @AASLDtweets Guidelines for NAFLD just released !! Two of the recommendations: 🔸STATINS should be used to prevent CVD events. 🔸ZERO ALCOHOL if significant fibrosis. @marurinella @DrLoomba #livertwitter #MedTwitter
Tweet media one
2
32
144
@rabataller
Ramon Bataller
2 years
They recently asked me: when is TOO LATE to stop alcohol drinking if you have end-stage cirrhosis ? Well, I’ve had cirrhotic drinkers sent to nursing homes for palliative care that recompensated because they couldn’t drink there. ANSWER: it’s never too late. #LiverTwitter
8
29
146
@rabataller
Ramon Bataller
12 days
Hepatorenal syndrome: 🔸Why does it happen ? 🔸How to diagnose and grade it ? 🔸How to use terlipressin and when is RRT needed? This great review in @AGA_Gastro tells you all. #livertwitter
Tweet media one
2
49
149
@rabataller
Ramon Bataller
3 years
We propose an algorithm to treat alcohol use disorder before and after liver transplantation. More clinical trials are needed in this field. @juanpabloarab @Lorenzo__Leggio @Dr_Vijay_Shah @manhalizzy #livertwitter
Tweet media one
2
54
143
@rabataller
Ramon Bataller
11 months
Do you know which is the most HARMFUL DRUG to the users and the people around them ? This study in @TheLancet showed that the number one is ALCOHOL. #livertwitter #MedTwitter
Tweet media one
7
66
143
@rabataller
Ramon Bataller
1 year
A massive study in >100,000 people in @LancetGastroHep shows that almost 3 out 4 people with obesity have FATTY LIVER. Who are more likely progress to cirrhosis/cancer ? 🔸Unfavorable genetic background 🔸Diabetics 🔸Drinkers & smokers #livertwitter #MedTwitter
Tweet media one
4
50
142
@rabataller
Ramon Bataller
2 years
Did you know that LIVER CANCER is one of the 3 top causes of cancer-related death in 46 countries ? And its incidence is rapidly growing due to fatty liver disease. #LiverCancerAwarenessMonth #livertwitter @JHepatology
Tweet media one
3
74
142
@rabataller
Ramon Bataller
2 years
Really proud of @juanpabloarab , a rising star in hepatology, who received the AWARD OF BEST YOUNG INVESTIGATOR from @ucatolica_chile @FacMedicinaUC . Mentored by @Dr_Vijay_Shah , he has made great contributions in the fields of ALD and NASH. #livertwitter @MayoClinicGIHep
Tweet media one
25
16
139
@rabataller
Ramon Bataller
2 years
In pilot study, we showed that RIFAXIMIN may be beneficial in ALCOHOLIC HEPATITIS: 🔸Less infections and muti-organ failure. 🔸Increased survival. This promising results need to be confirmed in a RCT. #livertwitter #medtwitter
Tweet media one
2
38
140
@rabataller
Ramon Bataller
2 years
Mentoring advice: mid career physicians and scientists have told me: "Ramon, why I am not invited to conferences or reviews ?" My answer: YOU NEED TO FOCUS. You have to find a topic and stick to it. Do the exercise below. Each dot represents a paper. #livertwitter #medtwitter
Tweet media one
6
29
137
@rabataller
Ramon Bataller
2 years
The LARGEST GENETIC study (>500k people) in liver patients in the @NEJM : 🔸Rare germline mutations explain why some people are resistant to develop liver disease. 🔸Mutations in genes regulating steatosis are protective against NASH. #LiverTwitter
Tweet media one
1
55
135
@rabataller
Ramon Bataller
1 month
Why does obesity increase all-type cancer ? Does weight loss decrease cancer risk ? This huge meta-analysis including 24M people reviews the mechanisms and shows that a weight loss of >5 kg reduces overall cancer risk. #livertwitter #MedX
Tweet media one
2
62
137
@rabataller
Ramon Bataller
6 months
When should we give PROPHYLACTIC ANTIBIOTICS in cirrhosis ? Do we prevent mortality or we promote multi-resistance ? This practical algorithm in @HepCommJournal guides us to follow an evidence-based and common sense approach. #livertwitter @ebtapper
Tweet media one
2
52
136
@rabataller
Ramon Bataller
1 year
The long-awaited trial on AMOXICILLIN-CLAVULANATE prophylaxis in alcohol-related hepatitis finally published in @JAMA_current : 🔸Well tolerated. 🔸No survival benefit. @AASLDtweets @EASLedu #livertwitter #medtwitter
Tweet media one
4
70
135
@rabataller
Ramon Bataller
2 years
#MentoringAdvice When I was on call in the past, I asked my fellows: please call me if you have any doubt. Only @jturnesv and @JuanAbraldes used to call me, and they are now very successful. ASKING for HELP is not a sign of weakness, but shows self-confidence. #livertwitter
9
32
134
@rabataller
Ramon Bataller
11 months
How can we predict clinical outcomes in NAFLD? Do we need biopsy? Are non-invasive tests good enough? A study in >2,500 biopsy-proven NAFLD in @LancetGastroHep shows that non-invasive tests are comparable to liver biopsy. #livertwitter #MedTwitter
Tweet media one
3
49
133
@rabataller
Ramon Bataller
1 year
Why ALT levels are normal/low in alcohol-associated hepatitis ? 🔸AH is NOT a necroinflammatory disease. It is mostly due to de-differentiation of hepatocytes. 🔸ALT is vitamin 6 -dependent and many patients with AH have profound vitamins deficiency. #livertwitter #medtwitter
0
27
135
@rabataller
Ramon Bataller
5 months
During my 30s and 40s, I mostly needed EXTERNAL validation (publications, positions, compliments..) In my 50s, I realized that INTERNAL validation is far more rewarding. I wish I would have known it earlier ! #mentoningadvice #livertwitter @EASLedu
7
12
132
@rabataller
Ramon Bataller
5 months
Acute-on-chronic liver failure is the most severe consequence of cirrhosis. What are the most promising THERAPIES ? This fantastic review by @RajivJalan1 et al. explains it all. @SeminLiverDis @DrPMonga #livertwitter
Tweet media one
1
54
130
@rabataller
Ramon Bataller
9 months
What is the BEST DIET for patients with fatty liver ? What is the scientific evidence supporting their health benefits ? This critical and didactic review explains it all. #livertwitter #MedTwitter @EASLedu
Tweet media one
1
51
130
@rabataller
Ramon Bataller
2 years
So proud to be part of a great team. The University of Barcelona number 4 in GI and Hepatology in the world ! Top Gastroenterology and Hepatology Schools in the World - US News Education @hospitalclinic @UniBarcelona @liverunitclinic #livertwitter
Tweet media one
6
28
126
@rabataller
Ramon Bataller
2 years
Why cirrhotics with infections are prone to bleed ? Besides increasing portal pressure, this study in @JHEP_Reports shows that infections impair PLATELET function. #LiverTwitter
Tweet media one
3
51
126
@rabataller
Ramon Bataller
2 years
I saw a patient with metabolic syndrome, a BMI of 38 and 5-6 beer consumption per day. If his fatty liver disease due to: 🔸NAFLD ? 🔸ALD ? 🔸Dual etiology ? See my answer in this minimalist graph. The dot represents this patient. #livertwitter @AASLDtweets @EASLedu
Tweet media one
15
27
125
@rabataller
Ramon Bataller
2 years
Kristen, the amazing addiction counselor that worked with me in Pittsburgh, sent me this cartoon. So true !!!! #MedTwitter #LiverTwitter
Tweet media one
6
16
127
@rabataller
Ramon Bataller
1 year
I've seen too many brilliant young doctors giving up on their dream to become a PHYSICIAN-SCIENTIST. It is a critical career path to translate science into medicine. ACADEMIC CENTERS should support it much more. @AASLDtweets #livertwitter @EASLedu
2
20
126
@rabataller
Ramon Bataller
7 months
Remember that the first objective in a patient with decompensated cirrhosis is achieving RECOMPENSATION. This great article in @NatRevGastroHep reviews the mechanisms of recompensation in fatty liver. @VirginiaHdezGea @GiadaSebastiani #livertwitter
Tweet media one
2
40
124
@rabataller
Ramon Bataller
2 years
Can we identify patients with alcoholic hepatitis that spontaneously recover and will not need an early liver transplant ? We showed in an international study that TRAJECTORY of BILIRUBIN is the key, regardless of the therapy. #MedTwitter #LiverTwitter
Tweet media one
4
35
122
@rabataller
Ramon Bataller
2 years
What are the most promising new therapies for NASH ? What are their mechanism of action ? This fantastic review in @JHepatology tells you all. #LiverTwitter @VladRatziu
Tweet media one
2
38
123
@rabataller
Ramon Bataller
2 years
This impressive study by Jay Luther @alcliverdoc shows that treating ALCOHOL USE DISORDER prevents liver-related decompensation. Drugs that show promise: 🔸Naltrexone 🔸Gabapentin 🔸Topiramate 🔸Baclofen #livertwitter
Tweet media one
7
28
124
@rabataller
Ramon Bataller
11 days
So sad about the passing of Stephen Harrison, one of the most influential leaders in hepatology, and a great person. His legacy, including the first drug for MASLD, his talent and his kind demeanor will remain with us. #livertwitter @EASLnews @AASLDtweets
Tweet media one
8
21
123
@rabataller
Ramon Bataller
2 years
A must-read review on one of the hottest topics in hepatology: IMMUNOTHERAPY-INDUCED LIVER INJURY. It includes: 🔸Pathogenesis. 🔸Grading. 🔸Management algorithm. #livertwitter #medtwitter
Tweet media one
9
42
120
@rabataller
Ramon Bataller
2 years
Do patients with Alc Hep have CIRRHOSIS? My answer: 🔸NO CIRRHOSIS (20%): huge liver, rapid recovery. 🔸EARLY CIRRHOSIS (50%): big liver, slower recovery, intermediate prognosis. 🔸ADVANCED CIRRHOSIS (30%): nodular liver in imaging, poor prognosis. #livertwitter #medtwitter
2
33
118
@rabataller
Ramon Bataller
1 year
The results from the IMPORTAL study by the @BavenoVII add a 3rd tenor to treat compensated cirrhosis: ANTICOAGULATION. These are the 3 TENORS in the current treatment of cirrhosis: 1. Statins 2. Carvedilol 3. Anticoagulants #medtwitter #livertwitter
Tweet media one
3
47
118
@rabataller
Ramon Bataller
8 months
Excellent update on HEPATOPULMONARY SYNDROME in @JHEP_Reports : 🔸Reviewed diagnostic criteria 🔸Window for liver transplant 🔸Pathogenesis and promising therapies @EASLedu #livertwitter #MedTwitter
Tweet media one
1
37
119
@rabataller
Ramon Bataller
2 years
Do you use PROCALCITONIN as a biomarker for infection in cirrhosis? In Alc Hep, we found that 83% of patients with >0.45 ng/mL were infected, as opposed to 29% of patients with <0.45 ng/mL. This could be useful in patients with isolated high white cell count. #livertwitter
Tweet media one
2
37
118
@rabataller
Ramon Bataller
2 years
Does sugar or sweetener decrease the beneficial effects of coffee? This large prospective study just showed that COFFEE DECREASES MORTALITY, but: 🔸Coffee only is the best 🔸Adding sweetener is OK 🔸Adding too much sugar is detrimental #livertwitter
Tweet media one
3
48
115
@rabataller
Ramon Bataller
2 years
Is it safe for the liver to drink heavily the WEEKEND and be sober during the rest of the week? Probably YES. But if you have METABOLIC SYNDROME, definitively NO. We explain it in this editorial with @CotsVentura #livertwitter
Tweet media one
3
39
115
@rabataller
Ramon Bataller
1 year
A study including >11k patients show that STATINS also decrease mortality in patients with acute-on-chronic liver failure (ACLF). Is there anything that statins can´t do for liver patients ? #LiverTwitter #MedTwitter @EASLedu @JHEP_Reports
Tweet media one
4
45
115
@rabataller
Ramon Bataller
2 years
Mentoring advice: before submitting a paper or a grant, PRINT it, get a pen, go to a quite place and read it carefully. If you have not found 10 mistakes, read it again. #livertwitter
4
14
115
@rabataller
Ramon Bataller
2 years
Mentoring advice: if you want to influence your workplace and be respected in your field, don’t underestimate the POWER of KINDNESS. #livertwitter
3
26
113
@rabataller
Ramon Bataller
1 year
We just showed that half of doctors don't discuss with their patients with alcoholic cirrhosis the need to get therapy for ALCOHOL USE DISORDER. I think that this will improve with more studies, training and awareness. #livertwitter #MedTwitter
Tweet media one
6
39
114
@rabataller
Ramon Bataller
6 months
I met a person top in his field that was taking notes during a lecture given by a young colleague. He tough me that the day we think we know everything, it will be the beginning of our career decline. #livertwitter #mentoringadvice @EASLedu
2
18
114
@rabataller
Ramon Bataller
10 months
This is a must-read review on DRUG-INDUCED AUTOIMMUNE-LIKE HEPATITIS. A unique entity in terms of diagnosis and management. The algorithm is very useful ! #livertwitter #medtwitter @EASL @JHepatology
Tweet media one
0
37
113
@rabataller
Ramon Bataller
8 months
Save this table: MEDICATIONS for treating alcohol use disorder. This is shown in a great article by Jessica Mellinger on practical recommendation to treat these patients. #livertwitter #MedTwitter @AmJGastro @UMich
Tweet media one
1
44
113
@rabataller
Ramon Bataller
1 year
WOMEN are more vulnerable to the effects of alcohol: 🔸More prone to develop cirrhosis and Alc Hep. 🔸More social STIGMA. 🔸Less access to liver transplantation. We need to protect them and tackle this problem ! #livertwitter #medtwitter
Tweet media one
8
43
112
@rabataller
Ramon Bataller
8 months
"ALCOHOL-INDUCED BOWEL DISEASE", a new concept that recapitulates all the profound changes that alcohol causes in GI tract. This article nicely reviews its clinical features and pathogenesis. #livertwitter #MedTwitter @eGastro_BMJ @NIAAAnews
Tweet media one
1
38
112
@rabataller
Ramon Bataller
2 years
What do acute pancreatitis and alcoholic hepatitis have in common ? 🔸They cause SIRS. 🔸SIRS (leukocytosis, fever, etc) can be STERILE. Serum PROCALCITONIN (an infection biomarker) can be useful to avoid unnecessary antibiotics. #livertwitter
Tweet media one
4
26
111
@rabataller
Ramon Bataller
1 year
My first thought when I first see a person with complicated cirrhosis is: can we RE-COMPENSATE it ? The best way is to treat the CAUSE such as alcohol. This article by @BavenoVII explains it all. #livertwitter #MedTwitter
Tweet media one
1
33
112
@rabataller
Ramon Bataller
13 days
Compared to ascites, hepatic HYDROTHORAX: - Poor response to diuretics, >AKI and HipoNa. - Repeated thoracocentesis is hard: consider TIPS. -Increased mortality with lower MELD. This study in @HEP_Journal shows its poor prognosis. #LiverTwitter
Tweet media one
1
41
112
@rabataller
Ramon Bataller
2 years
Many of the new drugs approved for cholestasis and also soon for NAFLD target BILE ACIDS (FXR agonists, FGF19, etc). This fantastic review discusses these emerging therapies. #livertwitter @NatRevGastroHep
Tweet media one
0
30
112
@rabataller
Ramon Bataller
2 years
In 2021 we identified a problem: NASH-HCC do not respond to immunotherapy. In 2022, a fascinating study by @derekamann1 found a solution: blocking neutrophil-derived CXCR2 sensitizes these tumors. Translational science advances medicine! #livertwitter
Tweet media one
1
31
109
@rabataller
Ramon Bataller
1 year
This is a must read seminar on HEMOCHROMATOSIS in @TheLancet - Why the European ancestry - Pathogenesis - Current therapy and drugs in the pipeline #livertwitter #MedTwitter
Tweet media one
1
35
110
@rabataller
Ramon Bataller
2 years
This AASLD meeting has 10 times more content on healthy diet, exercise and alcohol abstinence and the need of better public health policies. Finally we are tackling the root of the problem: in 2021, most liver diseases can be prevented !!! #livertwitter @AASLDtweets #LiverMtg21
Tweet media one
2
28
108
@rabataller
Ramon Bataller
2 years
Just a simple ECG can be useful to identify cirrhosis and its severity. The Mayo Clinic team is leading the field of using ARTIFICIAL INTELLIGENCE in hepatology! @JosephCAhnMD @DougSimonetto @Dr_Vijay_Shah @MayoClinicGIHep #LiverTwitter #MedTwitter
Tweet media one
1
40
109
@rabataller
Ramon Bataller
25 days
Why a thyroid hormone receptor- agonist has won the race as the 1st drug to treat MASLD ? This fantastic review on @Gut_BMJ explains the reasons. #MASLD #livertwitter #medX
Tweet media one
1
45
109
@rabataller
Ramon Bataller
1 year
How to treat PRURITUS in patients with cholestasis ? Sometimes, it is more difficult that treating pain. This great review in @NatRevGastroHep details the available therapies and their mechanism of action. #livertwitter #medtwitter
Tweet media one
1
39
107
@rabataller
Ramon Bataller
5 months
In my ALD clinic, I noticed that more than 30% of my patients have >2 components of the metabolic syndrome. Happy that @NatRevGastroHep devotes its cover to our article on this relevant clinical topic. @EASLedu #livertwitter #MedTwitter
Tweet media one
0
36
106
@rabataller
Ramon Bataller
3 months
These are the 3 hallmark papers of the evolving nomenclature from NASH, MAFLD to the non-stigmatizing MASLD. Happy to review this roadmap today, and the new concept of MetALD in the great annual @AEEHLiver meeting. #livertwitter #AEEH2024
Tweet media one
2
31
105
@rabataller
Ramon Bataller
8 months
🔸Why so many clinical trials are failing in fatty liver disease (NAFLD/MASLD) ? 🔸What are the most promising drugs in the pipeline ? This great review in @LancetGastroHep addresses these questions. #LiverTwitter #MedTwitter
Tweet media one
2
56
106
@rabataller
Ramon Bataller
1 year
Why so many clinical trials in NASH are failing ? - Placebo arms improve due to weight loss. - Heterogenous patients. - Need to better control the effect of underreported ALCOHOL: biomarkers needed! #livertwitter #MedTwitter
21
13
103